Sodium adenosine triphosphate (Sodium adenosintriphosphate)

Composition Pharmacodynamics Indications Carefully Contraindications Dosing and Administration Side effects Form release / dosage
Read on
Active substanceTrifosadeninTrifosadenin
Dosage form: & nbspsolution for intravenous administration
ATX: & nbsp

C.01.E.B   Other drugs for the treatment of heart disease

Terms of leave from pharmacies:On prescription
Registration number:LP-004667
Date of registration:25.01.2018
Expiration Date:25.01.2023
The owner of the registration certificate:ELLARA, LTD. ELLARA, LTD. Russia
Manufacturer: & nbsp
Information update date: & nbsp26.03.2018
Illustrated instructions
    Instructions
    Up
    talkdrugs

    +8 (800)555-35-35

    [email protected]

    The reference book of medicines of the Publishing Group "GEOTAR-Media" - the leader in the field of professional medical and pharmaceutical literature.

    The information on the preparations placed on the site is intended only for specialists. Drug descriptions can not be used by patients to make an independent decision on their use.

    It is forbidden to copy any instructions of medicines,biologically active additives or other information from the site www.talkdrugs.info without the written permission of the Publishing House "GEOTAR".

    All rights reserved. © Publishing group "GEOTAR-Media" 2008-2016.